C. Daige

发表

Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer

D. Brown, C. Daige, J. Wiggins, 2014, Molecular Cancer Therapeutics.

34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 2

C. Daige, J. Wiggins, Giulia Agnello, 2019, Journal of Immunotherapy for Cancer.

Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists

C. Daige, R. Tangirala, R. Heyman, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

Andrew C. Li, C. Daige, I. Schulman, 2010, Journal of lipid research.

Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).

Stefan Westin, Brett R. Murphy, C. Daige, 2009, Journal of medicinal chemistry.

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

F. Slack, J. Weidhaas, D. Brown, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

Aldons J. Lusis, Peter Tontonoz, D. Mangelsdorf, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth

M. V. Vander Heiden, C. Daige, J. Wiggins, 2021, Cancer Immunology Research.

Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

C. Glass, M. Rosenfeld, S. H. Baek, 2003, Molecular and Cellular Biology.

Non-redundant roles for LXRα and LXRβ in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice[S]

Andrew C. Li, C. Daige, I. Schulman, 2010, Journal of Lipid Research.

MRX34, a liposomal miR-34 mimic and potential first-in-class microRNA therapeutic: activity in animal models of liver cancer.

D. Brown, C. Daige, J. Wiggins, 2016 .

Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

Andrew C. Li, C. Daige, I. Schulman, 2010, Journal of lipid research.